[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
NIMAR – The list was updated 21.12.2022

NIMAR – The list was updated 21.12.2022

by Ryan Watts | Dec 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

NIMAR – The list was updated 21.12.2022

NIMAR – The list is getting longer…

by Sally Finlayson | Nov 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

Are you decommissioning products with the correct status?

Are you decommissioning products with the correct status?

by Sally Finlayson | Jun 1, 2021 | Blog, Brexit, Falsified Medicines, FMD, GDP/RP, Good Distribution Practice - GDP

The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

he UK MAs currently cover the whole of the “UK” so the UK MAs include Northern Ireland Supply…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

Lets start with the definition GB is now only…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in Northern Ireland (NI) need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

For Northern Irish Pharmacies FMD requirements have not changed and they must continue to verify and decommission their “2D” barcoded packs…

« Older Entries

Recent Posts

  • RP Refresher Training
  • The MHRA’s Guide to Defective Medicinal Products – Part 2
  • The MHRA’s Guide to Defective Medicinal Products – Part 1: Overview

Upcoming Courses

  • Export Online Training on 12 March 2026 10:00 am
  • Understanding GPhC Guidance for Online Pharmacies – Online Training on 16 March 2026
  • GDP/RP Cogent Gold Standard Online Training on 17 March 2026
  • GDP/RP Cogent Gold Standard WEEKEND Training on 20 March 2026 9:30 am
  • Introduction to Good Distribution Practice Online Training on 20 March 2026 10:00 am

MHRA Alerts & Recalls

Field Safety Notices: 02 to 06 March 2026
9 March 2026
Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11
6 March 2026
Field Safety Notices: 23-27 February 2026
3 March 2026
MHRA Safety Roundup: February 2026
25 February 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow